Obesity, high blood pressure, high cholesterol, and inactivity: they?re not just your father?s problems any more, University of New Hampshire research finds. New data on the widely unstudied demographic of college students indicates that this group of 18 ? 24-year-olds are on the path toward chronic health diseases. Although limited, national data suggest the trend is not unique to UNH.
New data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, sheds light on the role of environmental and genetic risk factors in the development of rheumatoid arthritis (RA).
Diabetes is often called a lifestyle disease, and now a new study from the University of Missouri-Columbia verifies that a lifestyle change brings strong improvements.
Alli is the first and only FDA-approved OTC product for weight loss. It is available in stores June 15. Dr. James Anderson, UK HealthCare weight loss researcher, studied the effects of the drug on mildly to moderately overweight individuals and found it does aid weight loss.
GlaxoSmithKline Consumer Healthcare [NYSE: GSK] announces that alli?, the only FDA-approved over-the-counter weight loss product will be on shelves of pharmacies, grocery stores and mass merchandisers nationwide later this week.
Scientists from the department of Biochemistry and Molecular Biology 1 of the University of Granada have proven that a high cholesterol diet causes changes in gene expression of chicken aortic smooth muscle cells at the early stages of an experimental atherosclerosis. This study associates cholesterol intake with the expression of genes codifying certain proteins, even before the disease is detected on blood vessel walls.
The U.S. Food and Drug Administration said that patients who took Acomplia, also known as Zimulti, in clinical trials were more likely to suffer from suicidal thoughts or actions than those on placebo.
Look at the clock. In the next three minutes, 10 people in America will suffer a coronary event or stroke, and only six of them will survive. According to a recent report by the American Heart Association (AHA), coronary heart disease (CHD) affects more than 15 million Americans; over five million more are affected by stroke.
Adding to a growing body of evidence, new research shows that a daily dose of pistachios may offer protective benefits against cardiovascular disease, according to a study published in the Volume 26, No. 2 issue of the Journal of the American College of Nutrition.
Schering-Plough Corporation (NYSE: SGP) and Bayer HealthCare today announced that ZETIA(R) (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestine, is now available in Japan for use in patients with hypercholesterolemia, familial hypercholesterolemia or homozygous sitosterolemia.